In conclusion, higher S-klotho levels are not associated with the
long-term risk of death in persons undergoing coronary angiography
and it does not modify the strong and established association
of FGF23 with mortality. Thus, it is unlikely that s-klotho will
qualify as a novel biomarker for cardiovascular risk.